Opinion
The 2019 Medicare proposed rule might just make your head explode
- Author:
- Brett M. Coldiron, MD
When sitting through interminable meetings, endless reports, and unfocused discussions, I often feel a building pressure in my head that, if it...
Opinion
Unlikely mentors
- Author:
- Brett M. Coldiron, MD
I understood I could meekly go along - or get angry. I chose the latter, and it has greatly changed my career.
Opinion
Why contribute to your political action committee?
- Author:
- Brett M. Coldiron, MD
Having a PAC gains you access and lets you be heard. In today's noisy world, it is not easy to get your congressional representative's attention...
Opinion
Melanoma in situ: It’s hard to know what you don’t know
- Author:
- Brett M. Coldiron, MD
A recently published study that found PAs performed 36% more skin biopsies per melanoma in situ diagnosed argues for closer collaboration to...
News
Tanning is the new tobacco
- Author:
- Brett M. Coldiron, MD
I still read and hear media reports about the health benefits of tanning.
News
The Rest of the Story: Anthem rescinds modifier 25 reductions
- Author:
- Brett M. Coldiron, MD
When I was a kid, there used to be a radio show by Paul Harvey called “The Rest of the Story.” I loved this show because there was always a big...
Opinion
It takes a missile to focus your mind
- Author:
- Brett M. Coldiron, MD
I was among the dermatologists sitting in a lecture hall during a meeting in Maui when our muted smartphones suddenly started howling in unison....
Opinion
Sentinel node biopsy: Who needs it?
- Author:
- Brett M. Coldiron, MD
If completion node dissection does not save lives, why do a sentinel node biopsy?
Opinion
‘We have met the enemy and he is us’
- Author:
- Brett M. Coldiron, MD
A New York Times analysis found that independent billing by PAs or NPs accounted for more than 15% of the skin biopsies billed to Medicare in 2015...
Opinion
Well, I figured it out ... I owe my soul to the company store
- Author:
- Brett M. Coldiron, MD
The basic plan of these groups is to pay you 5-8 times EBITDA up front, which works out to be about 2 or 3 years net profits.
Opinion
The Maintenance of Certification wars come to your state
- Author:
- Brett M. Coldiron, MD
While several states have passed anti-MOC legislation, not all are as comprehensive as the proposal in Ohio.
Opinion
Should you sell your dermatology practice?
- Author:
- Brett M. Coldiron, MD
There are advantages – and obvious disadvantages – to selling your dermatology practice to a large firm, Dr. Coldiron says.
Opinion
The tyranny of E&M reimbursement cuts with same-day procedures
- Author:
- Brett M. Coldiron, MD
It’s time to oppose insurers who halve E&M reimbursement when it’s performed on the same day as a procedure.
Opinion
Time for dermatologists in nine states to start submitting CPT code 99024
- Author:
- Brett M. Coldiron, MD
It’s time for dermatologists in nine states to start submitting CPT code 99024 for each postoperative visit.
Opinion
How to explain physician compounding to legislators
- Author:
- Brett M. Coldiron, MD
It’s time to convince legislators that physicians’ offices should be excluded from the USP and FDA definitions of compounding.